| # | Drug | Count |
|---|---|---|
| 0 | BINIMETINIB | 59 |
| 1 | ENCORAFENIB | 57 |
| 2 | NIVOLUMAB | 12 |
| 3 | RAMIPRIL | 12 |
| 4 | TRAMETINIB | 12 |
| 5 | ASPIRIN | 10 |
| 6 | ASPIRIN 325 MG | 10 |
| 7 | ASPIRIN 81 MG | 10 |
| 8 | COBIMETINIB | 10 |
| 9 | DEXAMETHASONE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BINIMETINIB | 59 | 0.0074 |
| 1 | ENCORAFENIB | 57 | 0.0056 |
| 2 | SELUMETINIB | 6 | 0.0036 |
| 3 | PEMIGATINIB | 2 | 0.0023 |
| 4 | COBIMETINIB | 10 | 0.0023 |
| 5 | ERDAFITINIB | 2 | 0.0016 |
| 6 | AVUTOMETINIB POTASSIUM AND DEFACTINIB HYDROCHLORIDE | 1 | 0.0009 |
| 7 | VEMURAFENIB | 9 | 0.0008 |
| 8 | TRAMETINIB | 12 | 0.0005 |
| 9 | DABRAFENIB | 8 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |
| 1 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 12 | 0.0001 |
| 2 | Angiotensin Converting Enzyme Inhibitor [EPC] | 12 | 0.0001 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 3 | 0.0001 |
| 4 | Calcineurin Inhibitor Immunosuppressant [EPC] | 6 | 0.0000 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Interleukin-6 Receptor Antagonist [EPC] | 6 | 0.0000 |
| 7 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Kinase Inhibitor [EPC] | 19 | 0.0000 |
| 9 | Phenothiazine [EPC] | 1 | 0.0000 |